ProAir Digihaler ProAir® Digihaler® (albuterol sulfate; Teva) Inhalation Powder is now available for patients aged ≥4 years for the treatment or prevention of bronchospasm with reversible obstructive ...

TEL AVIV, ISRAEL & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of AirDuo ® ...

Teva Respiratory LLC, an affiliate of Parsippany-based Teva Pharmaceutical Industries Ltd. announced on Monday that the U.S. Food and Drug Administration (FDA) approved ArmonAir Digihaler (fluticasone ...

- First and Only Digital Rescue Inhaler with Built-In Sensors Now Available By Prescription to Patients in the U.S. - Companion App Provides Objective Inhaler Event Data, Including Peak Inspiratory ...

The FDA has approved ArmonAir® Digihaler (fluticasone propionate; Teva) for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older. The Food and Drug ...

Asthma patients who use Teva Pharmaceutical’s Digihaler System are more likely to improve control of their condition than their counterparts who use standard-of-care albuterol inhalers, a 12-week ...

Healthcare is constantly adapting to meet the needs of patients. In our increasingly digital world, patients can have access to technology that may help them better understand respiratory conditions ...

Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler. The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four ...

Teva Respiratory, an affiliate of Teva Pharmaceutical Industries, completed its digital inhaler portfolio today with the launch of two new products: the AirDuo Digihaler and the ArmonAir Digihaler.

TEL AVIV, Israel & PARSIPPANY, N.J. & SAN ANTONIO--(BUSINESS WIRE)--Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the company is ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced new study findings based on newly ...

Castleford, UK Thursday 20 th July 2023 - Teva UK Limited today launched GoResp ® Digihaler ® i (budesonide / formoterol fumarate dihydrate) in the UK - the first country in Europe to make this ...